Quantcast

Latest Clinical research Stories

2014-06-30 23:14:05

This seminar will provide an in-depth snapshot of the key principles and requirements for advertising and promotion expectations and ensuring compliance success by David R. Dills, Regulatory & Compliance Consultant with more than 24 years of hands-on experience and a proven track record within the FDA regulated industry. San Diego, CA (PRWEB) June 30, 2014 The FDA regulates the promotion of prescription drugs, biologics, medical devices and biotechnology products to ensure that the...

2014-06-30 23:06:37

Western Digital Corporation’s Chief Financial Officer Brings Extensive Industry Experience to the Board of Privately Held OakGate loomis, California (PRWEB) June 30, 2014 OakGate Technology, the industry leader in test, validation and benchmarking platforms for storage products announced that Timothy M. Leyden, Chief Financial Officer of Western Digital Corporation, has joined its Board of Directors. Mr. Leyden becomes the fourth member of privately held OakGate Technology’s Board of...

2014-06-30 23:04:31

NutraGenesis announces a recent study published in the peer reviewed Journal of Clinical Psychiatry, the multi-patented, GRAS-affirmed, standardized Ashwagandha root and leaf extract, Sensoril®, was shown to improve several areas of cognitive effect in subjects with bipolar disorder. Brattleboro, VT (PRWEB) June 30, 2014 In a recent study published in the peer reviewed Journal of Clinical Psychiatry, the multi-patented, GRAS-affirmed, standardized Ashwagandha root and leaf extract,...

2014-06-30 16:29:22

SANTA MONICA, Calif., June 30, 2014 /PRNewswire-USNewswire/ -- A 2012 secret experiment in which Facebook manipulated users' news feed to see whether certain kinds of content made users happy or sad, violated basic research ethics, Consumer Watchdog said today. Results of the experiment, which also involved academic researchers, were published in the prestigious Proceedings of the National Academy of Sciences this month. "There is a longstanding rule that research involving human...

2014-06-30 12:32:22

NEW YORK, June 30, 2014 /PRNewswire/ -- FDNA(R) (http://www.fdna.com) - a pioneer in computer-aided dysmorphology analysis is proud to announce that four of Europe's leading thought leaders in genetics and human dysmorphology have been appointed to the steering committee of its Scientific Advisory Board (SAB). These appointments further strengthen the SABs strategic role in assisting FDNA on its mission to save lives and improve the quality of life of patients with rare or...

2014-06-30 12:32:12

FALLS CHURCH, Va., June 30, 2014 /PRNewswire-iReach/ -- Innovative Process Validation Strategies for Medical Devices: Proving Your Processes and Documentation to the FDA **Presented by Ombu Enterprises and FDAnews** Aug. 26-27, 2014 - Bethesda, MD http://www.fdanews.com/DeviceProcessValidation (Photo: http://photos.prnewswire.com/prnh/20140627/122807) FDAnews is pleased to announce its new interactive workshop -- Innovative Process Validation Strategies for Medical Devices: Proving Your...

2014-06-30 08:31:06

DUBLIN, June 30. 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/kzl2xt/clinical_trial) has announced the addition of the "2014 Report on the International Clinical Trial Management System Market - Forecast to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Clinical trial management system (CTMS) is a software solution for proper management, storage and analysis of drugs associated clinical data. Globally, the CTMS...

2014-06-30 08:29:59

DUBLIN, June 30, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate Sublingual Tablets, Eq, 1.4 mg/0.36 mg and 5.7 mg/1.4 mg Base. Actavis' ANDA product is a generic version of Orexo's Zubsolv(®), which is a partial opioid agonist indicated for the maintenance treatment of...

2014-06-27 23:10:35

In May 2014, the FDA released a draft guidance that covers the selection and approval process for proposed names of both prescription and nonprescription human drugs and biologics. FDAnews has teamed with drug-naming expert Dr. Susan Proulx to present a 90-minute webinar that will look closely at the draft guidance and its recommended 4-step process. Falls Church, VA (PRWEB) June 27, 2014 Choosing the Right Drug Name: How to Increase Your Chances for Approval **FDAnews Webinar** July...

2014-06-27 23:08:11

Roger Denton of Schlichter, Bogard & Denton, LLP reports that a recent lawsuit alleges that the blood thinning medication Xarelto® is linked to serious and life-threatening bleeding events. St. Louis, MO (PRWEB) June 27, 2014 According to a recent lawsuit filed in the Philadelphia County Court of Common Pleas (Stuntebeck v. Janssen Research & Development LLC et al, Case No.140201754), the anticoagulant drug Xarelto® (rivaroxaban) is alleged to cause serious and...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related